Fungal respiratory disease

Zhirong Yao1, Wanqing Liao

  • 1Medical Mycology Laboratory, Shanghai Jiaotong University Xinhua Hospital, Shanghai, China. zryaosmu@sohu.com

Abstract

Insights

Fungal respiratory diseases pose a significant threat to immunocompromised patients. Advances in diagnosis and treatment, including new antifungal agents and diagnostic tools, are crucial for improving outcomes in invasive fungal infections.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Fungal respiratory diseases are a leading cause of mortality in immunocompromised individuals.
  • Invasive fungal infections, such as aspergillosis and mucormycosis, present significant challenges in transplant recipients.

Purpose of the Study:

  • To review recent advancements in the etiology, clinical presentation, diagnosis, and management of fungal respiratory diseases.
  • To highlight the challenges and future directions in combating these infections.

Main Methods:

  • Literature review of recent studies on fungal respiratory diseases.
  • Analysis of diagnostic methods, including serological and molecular detection.
  • Evaluation of current and emerging therapeutic strategies.

Main Results:

  • Invasive aspergillosis in transplant patients is associated with poor outcomes.
  • Molecular diagnostics show variable sensitivity for pulmonary aspergillosis.
  • Newer antifungals like voriconazole and caspofungin are effective, particularly against resistant strains.
  • Combination therapy and prompt intervention improve mucormycosis prognosis.

Conclusions:

  • Invasive filamentous fungal infections remain a critical cause of death in immunocompromised patients.
  • Development of novel early diagnostic tools is essential.
  • Multicenter evaluations of diagnostic methods and therapeutic regimens are needed.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...